(For faster updates on individual market-movers, Eikon users
please use search string "STXBZ US"; for more market insights,
including options activity, ; for the Day Ahead
newsletter, link.reuters.com/mex49s; for the Morning News
Call newsletter, link.reuters.com/nex49s)
U.S. stocks were higher on Friday after the September jobs
report came in ahead of expectations, though major indexes
remained on track for a second straight weekly decline. The Dow
Jones industrial average was up 0.77 percent at 16,929.61
and the S&P 500 was up 0.86 percent at 1,962.86.

** ROCKWELL MEDICAL INC, $10.74, +16.99 pct

The drug developer signed a marketing agreement with a unit
of Baxter International Inc, according to which Baxter
will sell Rockwell's hemodialysis solutions and powders in the
United States and selected overseas markets for 10 years.

Baxter will pay $20 million in cash for exclusive commercial
rights and buy $15 million of company's common stock, Rockwell
said.

** DURATA THERAPEUTICS INC, $13.42, +13.44 pct

The company said it received a special protocol assessment
agreement from the U.S. Food and Drug Administration for its
late-stage study on its pneumonia drug, Dalvance.

A special protocol assessment agreement is a declaration by
the FDA that the company's trial design and endpoints are
acceptable for an approval.
Continued...